Trimi semaglutide review
Advertised at $99 and billed at $99 — no gap. Position 3 of 14 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
$99 a month on the annual plan, flat at every dose. Ties the semaglutide floor.
Three programmes advertise $99. Two bill it. Eden renews a $99 membership behind its headline and Mochi adds $79 — Trimi adds nothing.
The numbers
| Trimi · semaglutide | |
|---|---|
| Advertised | $99/mo |
| Membership | None |
| Billed | $99/mo |
| Advertised-to-billed gap | None |
| Per year | $1,188 |
| Board position | 3 of 14, cheapest first |
Annual-plan price, flat across the dose range, no membership behind it.
Where the gap is
No advert-to-bill gap. Annual commitment required for the headline rate.
Against the board
About $1,188 a year, level with Coreage Rx and ahead of Zealthy at $1,812, Mochi at $2,136 and Eden at $2,376.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $99 | $149 | +$50 | +$63/mo |
| Ozari Health | $86 | $86 | none | — |
| Trimi | $99 | $99 | none | +$13/mo |
| Zealthy | $151 | $151 | none | +$65/mo |
| Mochi Health | $99 | $178 | +$79 | +$92/mo |
| Hims & Hers | $79 | $188 | +$109 | +$102/mo |
| PlexusDx | $129 | $189 | +$60 | +$103/mo |
| Eden | $99 | $198 | +$99 | +$112/mo |
How the programme works
Flat-rate compounded GLP-1 programme on annual plans, with medical oversight through the Arora Health clinician network and publicly named 503A compounding pharmacies.
Verified facts
- Compounded tirzepatide advertised at $125/month on the annual plan.
- Compounded semaglutide advertised at $99/month on the annual plan.
- Price is the same at every prescribed dose.
- One flat charge covers medication, clinician visits, check-ins and free overnight shipping; no separate membership.
- Names its compounding pharmacies publicly: VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request.
- Medical oversight via Arora Health, a 50-state network led by Dr. Sean Arora, MD.
- Advertises a six-month money-back promise subject to terms.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- The cheapest verified flat rate for compounded tirzepatide in this comparison.
- Names its pharmacies with a licence number and offers a certificate of analysis — almost nobody else in this market does.
- Price does not move as your dose is adjusted.
- No membership fee stacked on the medication price.
Against it
- The headline rates require an annual commitment.
- Compounded medication only, with no route to branded Zepbound or Wegovy.
- Newer and smaller than the large platforms, with a shorter public track record.
Read this bit. Both headline prices are annual-plan rates. Confirm the month-to-month figure and the refund terms before prepaying twelve months.
Score
4.6 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 5 / 5 |
| Price honesty | 20% | 4.8 / 5 |
| Clinical support | 20% | 4 / 5 |
| Pharmacy sourcing | 15% | 4.8 / 5 |
| Cancelling | 15% | 4.2 / 5 |
Verdict
Joint cheapest on the board, and the only one at that price that publishes its pharmacy licences.
More from the desk
- Coreage Rx semaglutide review
Advertised at $99, billed at $149. Position 1 of 14 on our board.
- Ozari Health semaglutide review
Advertised at $86 and billed at $86 — no gap. Position 2 of 14 on our board.
- Zealthy semaglutide review
Advertised at $151 and billed at $151 — no gap. Position 4 of 14 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.